Apixaban inhibition of factor Xa: Microscopic rate constants and inhibition mechanism in purified protein systems and in human plasma

36Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Apixaban is a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. Rate constants for apixaban binding to free and prothrombinase-bound factor Xa were measured using multiple techniques. The inhibition mechanism was determined in purified systems and in a plasma prothrombin clotting time assay. Apixaban inhibits factor Xa with a K i of 0.25nM at 37°C, an association rate constant of approximately 20 μM -1 s -1, and a dissociation half-life of 12min. Under physiological conditions apixaban exhibits mixed-type inhibition and maintains high factor Xa affinity with a K i of 0.62nM and association rate constant of 12 μM -1 s -1 for prothrombinase, and a K i of 1.7nM and association rate constant of 4 μM -1 s -1 for the prothrombinase:prothrombin complex. Experiments in prothrombin depleted human plasma showed that the mechanism and kinetics of inhibition are maintained in plasma. The mechanistic detail derived from these experiments can be used to understand and interpret the pharmacodynamic action of apixaban. © 2011 Informa UK, Ltd.

Author supplied keywords

Cite

CITATION STYLE

APA

Luettgen, J. M., Knabb, R. M., He, K., Pinto, D. J. P., & Rendina, A. R. (2011). Apixaban inhibition of factor Xa: Microscopic rate constants and inhibition mechanism in purified protein systems and in human plasma. Journal of Enzyme Inhibition and Medicinal Chemistry, 26(4), 514–526. https://doi.org/10.3109/14756366.2010.535793

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free